September/October 2014

This activity is supported by educational grants from AbbVie Inc and LEO Pharma Inc.

Cyramza (ramucirumab) was approved for treatment of patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma after disease progression.

Individualized care programs can help patients with pulmonary arterial hypertension manage complex treatment regimens and overcome the challenges presented by this condition.

Specialty product manufacturers collaborate with specialty pharmacies because of the services and support pharmacies provide in their shared mission to achieve optimal clinical outcomes.

A retailer's decision to get involved in the specialty pharmacy marketplace should be an informed one that encompasses careful research and a full understanding of all of the stakeholder requirements.

The use of a virtual health assistant provides an ongoing measurement of patient outcomes and a precise picture of disease activity, allowing clinicians to better tailor medication therapy to a patient's needs.

Patient monitoring through a clinical management program allows clinicians to track outcomes and provide outreach, support, and education at key intervals in a patient's therapy.

A recent report by the Office of Inspector General examines the accuracy of average sales price data reporting.

Pharmacists need to be aware of the medication and policy trends governing the use of early-stage drugs that have not been approved by the FDA.

Specialty pharmacies face the complexities of managing relationships with patients, physicians, manufacturers, and payers.